Ozempic and yogurt, a Zepbound shortage, and Costco gets in on weight loss drugs: Pharma news round upByBruce GilPublishedApril 5, 2024
Nelson Peltz lost the Disney fight — but he did clear a cool $300 millionByBruce GilPublishedApril 4, 2024
The rise of Ozempic and Wegovy is good for the yogurt business, Danone CEO saysByBruce GilUpdatedApril 4, 2024
Disney and CEO Bob Iger beat Nelson Peltz, ending a long and costly board fightByBruce GilUpdatedApril 3, 2024
The U.K. is giving patients a treatment for the type of diabetes Ozempic can't treatByBruce GilUpdatedApril 2, 2024
Costco is now prescribing Ozempic, Wegovy, and other weight loss drugsByBruce GilPublishedApril 2, 2024
CVS, Humana and other health stocks are getting hit by lower than expected Medicare ratesByBruce GilPublishedApril 2, 2024
Google will delete billons of 'Incognito' browsing data records to settle a lawsuitByBruce GilUpdatedApril 1, 2024
Nelson Peltz's fight against Disney just got backing from the largest public pension fund in the U.S.ByBruce GilPublishedApril 1, 2024
Disney and Nelson Peltz keep fighting but the stock just keeps risingByBruce Gil and William GavinPublishedMarch 29, 2024
What to know about Disney CEO Bob Iger, Nelson Peltz, and their billion-dollar board fightByBruce Gil and William GavinUpdatedApril 1, 2024
Ozempic's cheaper side, weight loss drug competition, and Amazon delivery: Pharma news roundupByBruce GilPublishedMarch 29, 2024
